Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-07

AUTHORS

E. Garin, A. Devillers, J. Le Cloirec, A. M. Bernard, J. Lescouarc’h, J. Y. Herry, J. C. Reubi, P. Bourguet

ABSTRACT

. We conducted a prospective evaluation of somatostatin receptor scintigraphy (SRS) for the diagnosis of recurrent vesicular or papillary thyroid carcinoma in 16 patients with no detectable iodine uptake. SRS was performed 1, 4 and 24 h after intravenous injection of 137–200 MBq of indium-111 pentetreotide. Results were interpreted in terms of assumed presence of tumoral tissue: there were three true-positives (19%), one false-positive (6%) and 12 false-negatives (75%). The three true-positive patients had multiple lesions visible on computerized tomography. SRS was negative in all patients with a high thyroglobulin level alone. In addition, we analyzed the consequences of interpretative criteria and somatostatin receptor expression variability for SRS positivity as well as the risk of false-positives. We conclude that when iodine uptake cannot be demonstrated in patients with suspected recurrence of differentiated thyroid carcinoma, SRS would not appear to contribute to diagnosis, and that interpretative criteria commonly used for tumours with a high receptor density may be too restrictive for tumours with a low receptor density. More... »

PAGES

687-694

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002590050270

DOI

http://dx.doi.org/10.1007/s002590050270

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039055368

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9662589


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Papillary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "False Negative Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "False Positive Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indium Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Iodine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Iodine Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radionuclide Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Somatostatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Somatostatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyroglobulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyroid Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, X-Ray Computed", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garin", 
        "givenName": "E.", 
        "id": "sg:person.0620512077.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620512077.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Devillers", 
        "givenName": "A.", 
        "id": "sg:person.0661113347.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661113347.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Cloirec", 
        "givenName": "J.", 
        "id": "sg:person.01237213403.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237213403.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bernard", 
        "givenName": "A. M.", 
        "id": "sg:person.0602263753.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602263753.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lescouarc\u2019h", 
        "givenName": "J.", 
        "id": "sg:person.0601727202.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601727202.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Herry", 
        "givenName": "J. Y.", 
        "id": "sg:person.012116171367.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012116171367.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Pathology, University of Berne, Switzerland, CH", 
          "id": "http://www.grid.ac/institutes/grid.5734.5", 
          "name": [
            "Institute of Pathology, University of Berne, Switzerland, CH"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reubi", 
        "givenName": "J. C.", 
        "id": "sg:person.01305310442.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305310442.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, CRLCC Eug\u00e8ne Marquis, Rennes, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bourguet", 
        "givenName": "P.", 
        "id": "sg:person.0620506232.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620506232.31"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00181765", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016946247", 
          "https://doi.org/10.1007/bf00181765"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00238123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008201843", 
          "https://doi.org/10.1007/bf00238123"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02067319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029129993", 
          "https://doi.org/10.1007/bf02067319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00173035", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032916280", 
          "https://doi.org/10.1007/bf00173035"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-07", 
    "datePublishedReg": "1998-07-01", 
    "description": "Abstract. We conducted a prospective evaluation of somatostatin receptor scintigraphy (SRS) for the diagnosis of recurrent vesicular or papillary thyroid carcinoma in 16 patients with no detectable iodine uptake. SRS was performed 1, 4 and 24\u00a0h after intravenous injection of 137\u2013200\u00a0MBq of indium-111 pentetreotide. Results were interpreted in terms of assumed presence of tumoral tissue: there were three true-positives (19%), one false-positive (6%) and 12 false-negatives (75%). The three true-positive patients had multiple lesions visible on computerized tomography. SRS was negative in all patients with a high thyroglobulin level alone. In addition, we analyzed the consequences of interpretative criteria and somatostatin receptor expression variability for SRS positivity as well as the risk of false-positives. We conclude that when iodine uptake cannot be demonstrated in patients with suspected recurrence of differentiated thyroid carcinoma, SRS would not appear to contribute to diagnosis, and that interpretative criteria commonly used for tumours with a high receptor density may be too restrictive for tumours with a low receptor density.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002590050270", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "keywords": [
      "somatostatin receptor scintigraphy", 
      "thyroid carcinoma", 
      "iodine uptake", 
      "receptor scintigraphy", 
      "receptor density", 
      "true-positive patients", 
      "high thyroglobulin levels", 
      "recurrent thyroid carcinoma", 
      "differentiated thyroid carcinoma", 
      "high receptor density", 
      "papillary thyroid carcinoma", 
      "interpretative criteria", 
      "low receptor density", 
      "thyroglobulin levels", 
      "prospective evaluation", 
      "indium-111 pentetreotide", 
      "multiple lesions", 
      "intravenous injection", 
      "computerized tomography", 
      "patients", 
      "tumoral tissue", 
      "carcinoma", 
      "scintigraphy", 
      "tumors", 
      "diagnosis", 
      "pentetreotide", 
      "uptake", 
      "recurrence", 
      "lesions", 
      "MBq", 
      "positivity", 
      "tomography", 
      "injection", 
      "risk", 
      "criteria", 
      "tissue", 
      "levels", 
      "evaluation", 
      "presence", 
      "use", 
      "addition", 
      "consequences", 
      "expression variability", 
      "variability", 
      "results", 
      "density", 
      "terms", 
      "detectable iodine uptake", 
      "somatostatin receptor expression variability", 
      "receptor expression variability", 
      "SRS positivity", 
      "indium-111 pentetreotide somatostatin receptor scintigraphy", 
      "pentetreotide somatostatin receptor scintigraphy"
    ], 
    "name": "Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake", 
    "pagination": "687-694", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039055368"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002590050270"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9662589"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002590050270", 
      "https://app.dimensions.ai/details/publication/pub.1039055368"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_288.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002590050270"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002590050270'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002590050270'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002590050270'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002590050270'


 

This table displays all metadata directly associated to this object as RDF triples.

271 TRIPLES      22 PREDICATES      106 URIs      94 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002590050270 schema:about N1bb49547fb37439ea67668f8e247e618
2 N1d655328a4074fa2adf8cfcfc717b104
3 N2ba9a34eb4e64d758b95fa63cf66657a
4 N43af4a4a0f894115974604a2dd38d97e
5 N4f7779d8bb774b32aa12e6e1f107dc84
6 N6c19368d376c49c29a4eded57998c7c9
7 N6e67f2ce25f24f5c812d7bed7c8e76a9
8 N7394c27cf2b64176b5e896c1ccce0dcd
9 N796522877b8c43e29c990a863ff906ee
10 N7b6550ed48484e9789e78181f06291c6
11 N8c46f14809d64f9c9766df7abb1ba90f
12 N8c7dddbdedcf4c60b234ead6077db1ee
13 N9f13953b8e3a404cbef88fab7afd7306
14 Nb201e9f1aa7943b2821683e79e49da60
15 Nb29c648ac4b940aca3ea7e3102401595
16 Nbeb86c3ee650415c9497e91c6fec5ca9
17 Nc5ad44a44deb44cdba851b73526615f5
18 Nca59213adfdb42a2b7e9537b81d142cc
19 Ncdcf6a2daf984ee680f45ac77e16f6c7
20 Nde50aad49e60452f990345fd3ce1b20b
21 Nf24d5dcf5062447987590729cc9b9f64
22 Nf5f145763b3a47c69c771a6931d9ade8
23 anzsrc-for:11
24 anzsrc-for:1103
25 schema:author N1781f06dabb24044906489b92cf73af8
26 schema:citation sg:pub.10.1007/bf00173035
27 sg:pub.10.1007/bf00181765
28 sg:pub.10.1007/bf00238123
29 sg:pub.10.1007/bf02067319
30 schema:datePublished 1998-07
31 schema:datePublishedReg 1998-07-01
32 schema:description Abstract. We conducted a prospective evaluation of somatostatin receptor scintigraphy (SRS) for the diagnosis of recurrent vesicular or papillary thyroid carcinoma in 16 patients with no detectable iodine uptake. SRS was performed 1, 4 and 24 h after intravenous injection of 137–200 MBq of indium-111 pentetreotide. Results were interpreted in terms of assumed presence of tumoral tissue: there were three true-positives (19%), one false-positive (6%) and 12 false-negatives (75%). The three true-positive patients had multiple lesions visible on computerized tomography. SRS was negative in all patients with a high thyroglobulin level alone. In addition, we analyzed the consequences of interpretative criteria and somatostatin receptor expression variability for SRS positivity as well as the risk of false-positives. We conclude that when iodine uptake cannot be demonstrated in patients with suspected recurrence of differentiated thyroid carcinoma, SRS would not appear to contribute to diagnosis, and that interpretative criteria commonly used for tumours with a high receptor density may be too restrictive for tumours with a low receptor density.
33 schema:genre article
34 schema:inLanguage en
35 schema:isAccessibleForFree false
36 schema:isPartOf N93c288553e0c4fbe8c6768f10381d1b8
37 Ne1aa2023e42c41faad4b613dc29227f2
38 sg:journal.1297401
39 schema:keywords MBq
40 SRS positivity
41 addition
42 carcinoma
43 computerized tomography
44 consequences
45 criteria
46 density
47 detectable iodine uptake
48 diagnosis
49 differentiated thyroid carcinoma
50 evaluation
51 expression variability
52 high receptor density
53 high thyroglobulin levels
54 indium-111 pentetreotide
55 indium-111 pentetreotide somatostatin receptor scintigraphy
56 injection
57 interpretative criteria
58 intravenous injection
59 iodine uptake
60 lesions
61 levels
62 low receptor density
63 multiple lesions
64 papillary thyroid carcinoma
65 patients
66 pentetreotide
67 pentetreotide somatostatin receptor scintigraphy
68 positivity
69 presence
70 prospective evaluation
71 receptor density
72 receptor expression variability
73 receptor scintigraphy
74 recurrence
75 recurrent thyroid carcinoma
76 results
77 risk
78 scintigraphy
79 somatostatin receptor expression variability
80 somatostatin receptor scintigraphy
81 terms
82 thyroglobulin levels
83 thyroid carcinoma
84 tissue
85 tomography
86 true-positive patients
87 tumoral tissue
88 tumors
89 uptake
90 use
91 variability
92 schema:name Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake
93 schema:pagination 687-694
94 schema:productId N44017b6e1fb84b02a1c00f31517b9165
95 N53321daeb348429b839d0df3cb5d9bd6
96 N834d34404bf04c8cbb2f5bde9d368d9d
97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039055368
98 https://doi.org/10.1007/s002590050270
99 schema:sdDatePublished 2022-01-01T18:08
100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
101 schema:sdPublisher Nae74b86ddac6497ca6321edca09a93d9
102 schema:url https://doi.org/10.1007/s002590050270
103 sgo:license sg:explorer/license/
104 sgo:sdDataset articles
105 rdf:type schema:ScholarlyArticle
106 N1781f06dabb24044906489b92cf73af8 rdf:first sg:person.0620512077.06
107 rdf:rest N69de6dd1236a4584b3f49c245be20773
108 N1bb49547fb37439ea67668f8e247e618 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Male
110 rdf:type schema:DefinedTerm
111 N1d655328a4074fa2adf8cfcfc717b104 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Radionuclide Imaging
113 rdf:type schema:DefinedTerm
114 N2ba9a34eb4e64d758b95fa63cf66657a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Radiopharmaceuticals
116 rdf:type schema:DefinedTerm
117 N43af4a4a0f894115974604a2dd38d97e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Middle Aged
119 rdf:type schema:DefinedTerm
120 N44017b6e1fb84b02a1c00f31517b9165 schema:name pubmed_id
121 schema:value 9662589
122 rdf:type schema:PropertyValue
123 N491dda59bfb945a0b75488faaecd6eeb rdf:first sg:person.01305310442.53
124 rdf:rest Na636791b67f94827ad0f77047bfd45e4
125 N4f7779d8bb774b32aa12e6e1f107dc84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Prospective Studies
127 rdf:type schema:DefinedTerm
128 N53321daeb348429b839d0df3cb5d9bd6 schema:name doi
129 schema:value 10.1007/s002590050270
130 rdf:type schema:PropertyValue
131 N69de6dd1236a4584b3f49c245be20773 rdf:first sg:person.0661113347.52
132 rdf:rest Nef28a946cd224fd786a7998043e39dd7
133 N6c19368d376c49c29a4eded57998c7c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Thyroglobulin
135 rdf:type schema:DefinedTerm
136 N6e67f2ce25f24f5c812d7bed7c8e76a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Iodine
138 rdf:type schema:DefinedTerm
139 N7394c27cf2b64176b5e896c1ccce0dcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Tomography, X-Ray Computed
141 rdf:type schema:DefinedTerm
142 N796522877b8c43e29c990a863ff906ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Female
144 rdf:type schema:DefinedTerm
145 N7b6550ed48484e9789e78181f06291c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Humans
147 rdf:type schema:DefinedTerm
148 N834d34404bf04c8cbb2f5bde9d368d9d schema:name dimensions_id
149 schema:value pub.1039055368
150 rdf:type schema:PropertyValue
151 N8c46f14809d64f9c9766df7abb1ba90f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Carcinoma, Papillary
153 rdf:type schema:DefinedTerm
154 N8c7dddbdedcf4c60b234ead6077db1ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Somatostatin
156 rdf:type schema:DefinedTerm
157 N93c288553e0c4fbe8c6768f10381d1b8 schema:issueNumber 7
158 rdf:type schema:PublicationIssue
159 N9f13953b8e3a404cbef88fab7afd7306 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Aged, 80 and over
161 rdf:type schema:DefinedTerm
162 Na636791b67f94827ad0f77047bfd45e4 rdf:first sg:person.0620506232.31
163 rdf:rest rdf:nil
164 Nad7b9ae9f1794298be4cc18c59d05b1c rdf:first sg:person.0602263753.68
165 rdf:rest Nc618c210d1944b83a23fc3b8ba4d21af
166 Nae74b86ddac6497ca6321edca09a93d9 schema:name Springer Nature - SN SciGraph project
167 rdf:type schema:Organization
168 Nb201e9f1aa7943b2821683e79e49da60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Iodine Radioisotopes
170 rdf:type schema:DefinedTerm
171 Nb29c648ac4b940aca3ea7e3102401595 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Receptors, Somatostatin
173 rdf:type schema:DefinedTerm
174 Nbeb86c3ee650415c9497e91c6fec5ca9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Thyroid Neoplasms
176 rdf:type schema:DefinedTerm
177 Nc5ad44a44deb44cdba851b73526615f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Adult
179 rdf:type schema:DefinedTerm
180 Nc618c210d1944b83a23fc3b8ba4d21af rdf:first sg:person.0601727202.11
181 rdf:rest Nde814858526b4e91a088fbc40f229efc
182 Nca59213adfdb42a2b7e9537b81d142cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name False Negative Reactions
184 rdf:type schema:DefinedTerm
185 Ncdcf6a2daf984ee680f45ac77e16f6c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name False Positive Reactions
187 rdf:type schema:DefinedTerm
188 Nde50aad49e60452f990345fd3ce1b20b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Recurrence
190 rdf:type schema:DefinedTerm
191 Nde814858526b4e91a088fbc40f229efc rdf:first sg:person.012116171367.06
192 rdf:rest N491dda59bfb945a0b75488faaecd6eeb
193 Ne1aa2023e42c41faad4b613dc29227f2 schema:volumeNumber 25
194 rdf:type schema:PublicationVolume
195 Nef28a946cd224fd786a7998043e39dd7 rdf:first sg:person.01237213403.13
196 rdf:rest Nad7b9ae9f1794298be4cc18c59d05b1c
197 Nf24d5dcf5062447987590729cc9b9f64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Aged
199 rdf:type schema:DefinedTerm
200 Nf5f145763b3a47c69c771a6931d9ade8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Indium Radioisotopes
202 rdf:type schema:DefinedTerm
203 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
204 schema:name Medical and Health Sciences
205 rdf:type schema:DefinedTerm
206 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
207 schema:name Clinical Sciences
208 rdf:type schema:DefinedTerm
209 sg:journal.1297401 schema:issn 1619-7070
210 1619-7089
211 schema:name European Journal of Nuclear Medicine and Molecular Imaging
212 schema:publisher Springer Nature
213 rdf:type schema:Periodical
214 sg:person.012116171367.06 schema:affiliation grid-institutes:None
215 schema:familyName Herry
216 schema:givenName J. Y.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012116171367.06
218 rdf:type schema:Person
219 sg:person.01237213403.13 schema:affiliation grid-institutes:None
220 schema:familyName Le Cloirec
221 schema:givenName J.
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237213403.13
223 rdf:type schema:Person
224 sg:person.01305310442.53 schema:affiliation grid-institutes:grid.5734.5
225 schema:familyName Reubi
226 schema:givenName J. C.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305310442.53
228 rdf:type schema:Person
229 sg:person.0601727202.11 schema:affiliation grid-institutes:None
230 schema:familyName Lescouarc’h
231 schema:givenName J.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601727202.11
233 rdf:type schema:Person
234 sg:person.0602263753.68 schema:affiliation grid-institutes:None
235 schema:familyName Bernard
236 schema:givenName A. M.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602263753.68
238 rdf:type schema:Person
239 sg:person.0620506232.31 schema:affiliation grid-institutes:None
240 schema:familyName Bourguet
241 schema:givenName P.
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620506232.31
243 rdf:type schema:Person
244 sg:person.0620512077.06 schema:affiliation grid-institutes:None
245 schema:familyName Garin
246 schema:givenName E.
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620512077.06
248 rdf:type schema:Person
249 sg:person.0661113347.52 schema:affiliation grid-institutes:None
250 schema:familyName Devillers
251 schema:givenName A.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661113347.52
253 rdf:type schema:Person
254 sg:pub.10.1007/bf00173035 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032916280
255 https://doi.org/10.1007/bf00173035
256 rdf:type schema:CreativeWork
257 sg:pub.10.1007/bf00181765 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016946247
258 https://doi.org/10.1007/bf00181765
259 rdf:type schema:CreativeWork
260 sg:pub.10.1007/bf00238123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008201843
261 https://doi.org/10.1007/bf00238123
262 rdf:type schema:CreativeWork
263 sg:pub.10.1007/bf02067319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029129993
264 https://doi.org/10.1007/bf02067319
265 rdf:type schema:CreativeWork
266 grid-institutes:None schema:alternateName Department of Nuclear Medicine, CRLCC Eugène Marquis, Rennes, France, FR
267 schema:name Department of Nuclear Medicine, CRLCC Eugène Marquis, Rennes, France, FR
268 rdf:type schema:Organization
269 grid-institutes:grid.5734.5 schema:alternateName Institute of Pathology, University of Berne, Switzerland, CH
270 schema:name Institute of Pathology, University of Berne, Switzerland, CH
271 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...